- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 33/02 - Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
Patent holdings for IPC class A61P 33/02
Total number of patents in this class: 970
10-year publication summary
|
45
|
51
|
62
|
69
|
68
|
83
|
70
|
53
|
49
|
23
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Novartis AG | 10338 |
20 |
| CEVA Sante Animale | 714 |
15 |
| Anacor Pharmaceuticals, Inc. | 63 |
11 |
| Universidade Federal de Minas Gerais - Ufmg | 194 |
11 |
| Consejo Superior de Investigaciones Cientificas (csic) | 1431 |
10 |
| Centre National de La Recherche Scientifique | 10914 |
9 |
| Fundacao Oswaldo Cruz | 108 |
9 |
| Nihon Nohyaku Co., Ltd. | 326 |
9 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2980 |
9 |
| Bayer Animal Health GmbH | 174 |
8 |
| Universidad de Granada | 310 |
8 |
| University of Dundee | 219 |
8 |
| Glaxosmithkline Intellectual Property Development Limited | 774 |
7 |
| The Board of Trustees of the Leland Stanford Junior University | 6615 |
7 |
| President and Fellows of Harvard College | 6060 |
7 |
| CJ Cheiljedang Corporation | 3600 |
7 |
| Griffith University | 160 |
7 |
| Institut de Recherche pour le Developpement (ird) | 150 |
7 |
| The United States of America, as represented by the Secretary of Agriculture | 1145 |
7 |
| Zivo BioScience, Inc. | 53 |
7 |
| Other owners | 787 |